Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping

Paul K. Paik, Alexander Drilon, Pang Dian Fan, Helena Yu, Natasha Rekhtman, Michelle S. Ginsberg, Laetitia Borsu, Nikolaus Schultz, Michael F. Berger, Charles M. Rudin, Marc Ladanyi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping'. Together they form a unique fingerprint.

Medicine & Life Sciences